Ardent Health ROA 2022-2025 | ARDT
Current and historical return on assets (ROA) values for Ardent Health (ARDT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Ardent Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $0.21B | $5.15B | 4.09% |
| 2025-06-30 | $0.25B | $5.03B | 5.16% |
| 2025-03-31 | $0.22B | $4.91B | 4.65% |
| 2024-12-31 | $0.21B | $4.96B | 5.85% |
| 2024-06-30 | $0.09B | $4.61B | 7.90% |
| 2024-03-31 | $0.08B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.357B | $5.966B |
| Ardent Health Partners Inc. is a provider of healthcare. Ardent Health Partners Inc., formerly known as ARDENT HEALTH, is based in BRENTWOOD, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.823B | 27.56 |
| HCA Healthcare (HCA) | United States | $119.687B | 18.94 |
| CVS Health (CVS) | United States | $99.143B | 11.55 |
| Elevance Health (ELV) | United States | $74.166B | 11.14 |
| Cencora (COR) | United States | $68.103B | 21.49 |
| Natera (NTRA) | United States | $28.748B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.055B | 17.58 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.186B | 6.78 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.455B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.173B | 12.79 |
| Medpace Holdings (MEDP) | United States | $11.808B | 27.19 |
| CochLear (CHEOY) | Australia | $11.290B | 0.00 |
| Revvity (RVTY) | United States | $10.835B | 18.85 |
| Charles River Laboratories (CRL) | United States | $7.812B | 15.05 |
| Sonic Healthcare (SKHHY) | Australia | $7.666B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.816B | 40.63 |
| ICON (ICLR) | Ireland | $6.467B | 6.42 |
| HealthEquity (HQY) | United States | $6.255B | 23.39 |
| Avantor (AVTR) | United States | $6.234B | 10.04 |
| PACS (PACS) | United States | $6.094B | 37.06 |
| Bausch + Lomb (BLCO) | Canada | $5.927B | 38.91 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.826B | 0.00 |
| Sotera Health (SHC) | United States | $4.821B | 23.25 |
| Alignment Healthcare (ALHC) | United States | $4.012B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.062B | 19.11 |
| GeneDx Holdings (WGS) | United States | $2.621B | 46.03 |
| Establishment Labs Holdings (ESTA) | United States | $2.137B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.004B | 25.82 |
| Organon (OGN) | United States | $1.835B | 2.06 |
| Pediatrix Medical (MD) | United States | $1.809B | 10.81 |
| Progyny (PGNY) | United States | $1.809B | 35.56 |
| InnovAge Holding (INNV) | United States | $1.133B | 167.00 |
| CareDx (CDNA) | United States | $0.982B | 16.05 |
| Teladoc Health (TDOC) | United States | $0.793B | 0.00 |
| Nutex Health (NUTX) | United States | $0.743B | 5.68 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Omada Health (OMDA) | United States | $0.650B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.638B | 0.00 |
| Embecta (EMBC) | United States | $0.592B | 3.30 |
| Enhabit (EHAB) | United States | $0.568B | 25.50 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.562B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.475B | 8.74 |
| CryoPort (CYRX) | United States | $0.413B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Strata Critical Medical (SRTA) | United States | $0.380B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.364B | 5.86 |
| So-Young (SY) | China | $0.348B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.283B | 0.00 |
| Oncology Institute (TOI) | United States | $0.235B | 0.00 |
| Agilon Health (AGL) | United States | $0.151B | 0.00 |
| LifeMD (LFMD) | United States | $0.135B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.104B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
| Biodesix (BDSX) | United States | $0.086B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.075B | 0.00 |
| DocGo (DCGO) | United States | $0.069B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Pomdoctor - (POM) | China | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 5.69 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |